Today’s AI Top Pick: BILI

8/12/2026 · Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · BILI76%363 resolved forecasts · 45d window · verify →

Today's pick · TurnaroundBILIBUY NOW8.4 / 108/12/2026

BILI is the cleanest multi-timeframe setup in the pool right now with no news landmines undercutting it. All three timeframes point up: 4h forecasts +31.66/+47.31/+53.63%, 1d forecasts +24.63/+42.83/+36.14%, and even the 1wk shows +4.11/-0.74/+20.61% — the near-term bullish score is a maxed-out 1.0 and Kronos bullish_prob is 1.0. Crucially, it is NOT at the top of the range: pos_in_21bar_range is 37.47% (4h), 28.85% (1d), and 14.86% (1wk), with modest drawdowns (-6.5% / -7.69% / -29.38%). That is the ideal 'coiled but not chased' profile the framework rewards. The fundamentals confirm the setup: recom 1.32 (strong buy), targetUpsidePct 59.5%, PEG 0.52, fwdPe 13.47, EPS next year growth 27.1%, sales YoY +11.2%, debt/equity 0.61, and profitMargin 4.58% turning up from a base. It is not the cheapest name here on absolute basis, but it is the best combination of valuation + growth + signal alignment. Perf 1Y -22.22% satisfies the turnaround screen without the extreme -50%+ carnage seen in APP/WING/ALNY that often signals real fundamental damage. The news check is the tiebreaker that puts BILI over otherwise-attractive setups. FUTU has a DOJ probe headline (kills it as a #1). APP was just downgraded by BofA with a 'growth target harder to defend' narrative. SRAD cut 2026 guidance and got a UBS downgrade. ALNY's 1wk forecast is negative and it appeared in a 'drugs that missed the mark' article. ONON dropped 17.8% on mixed guidance. NRG's 1wk forecasts are deeply negative. BILI's recent headlines are neutral-to-positive ('Undervalued Or Is Its Recent Bounce Already Priced In?') with no guidance cut, no legal issue, no dilution. Why today vs. waiting: with 4h and 1d both showing large positive forecasts AND the stock sitting at the lower third of its 21-bar range, you don't need a further pullback — the pullback already happened (-7.69% dd on daily). Waiting risks missing the mean-reversion move that the short-term forecast (+24.63% on 1d) is signaling.

Entry zone

$17.40–$17.90 (current $17.76, scale in on any dip to the $17.20 support)

Stop loss

$16.20 (below the 21-bar weekly low, ~9% risk)

First target

$21.50 (roughly the 4h forecast fc_short of +21%, matches recent supply zone)

Longer target

$25–$27 (fc_mid/long of +42-53% on 4h/1d, aligns with 59.5% analyst target upside)

Risks

Weekly forecast is only marginally positive (fc_mid -0.74%), so multi-week upside is less certain than 1–4 week move
China ADR sentiment risk — any escalation of US-China listing/regulatory friction hits BILI disproportionately
Low institutional ownership (13.2%) means thinner sponsorship and higher volatility on macro moves
Operating margin only 4.13% and profit margin 4.58% — profitability is thin and any revenue miss compresses earnings sharply
Short float 5.88% is manageable but the stock can be reflexive to broad tech risk-off given -22% 1Y perf

Honorable mentions

INTRExtremely cheap (PE 7.97, PEG 0.22, fwdPe 5.26), forecasts massive (4h +56/65/72%, 1d +14/49/42%), pos_in_range 9.85% on 1d with -37.63% weekly drawdown = deeply oversold. Recent Q2 was record profitability yet stock sold off 5.9% — classic misread the market can correct. Only reason it's not #1 is 1wk fc mid is -0.57% and analyst recom 1.83 is weaker than BILI's 1.32.

FICODeep oversold turnaround — pos_in_range 2.82% (4h) and 0.94% (1d) with -24.61% daily drawdown, yet 4h forecasts +33/25/36% and 1d +10/38/40%. Best-in-class fundamentals (grossMargin 85.1%, operMargin 52.11%, profitMargin 34.05%). Barclays cut PT but maintained Overweight — soft negative, not a killer.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	BILI	BUY NOW	8.4	MTF alignment (4h/1d/1wk all positive), mid-range positioning, near_term_bullish 1.0, clean news — cleanest setup in the pool.
2	INTR	BUY NOW	8.2	Cheapest name (fwdPe 5.26, PEG 0.22) with massive 4h fc (+56/65/72%) and deeply oversold weekly (-37.6% dd).
3	FICO	BUY NOW	7.9	Bottom-of-range oversold (pos 0.94% on 1d) with 4h/1d forecasts +30-40%; elite margins, Barclays still Overweight.
4	ALNY	BUY PULLBACK	7.4	Forecasts massive (4h +73%, 1d +57%) and near-term bullish 1.0, but 1wk fc negative and 'missed the mark' headline weighs.
5	CALX	BUY PULLBACK	7.2	Strong fundamentals and forecasts (+43% 4h long) but pos_in_range 100% on 4h = extended, wait for dip to ~$36.
6	MLCO	BUY PULLBACK	7.0	Cheap (PE 9.52, PEG 0.36) with 1wk fc +32/+44%, but pos_in_range 100% on 4h and only 0.4 near-term bullish.
7	WMG	BUY NOW	6.9	Pos_in_range 0% across 1h/4h/1d, strong Q3 earnings, PEG 0.31, fc +14-19% on 1d/1wk long.
8	BIRK	BUY PULLBACK	6.6	Reasonable valuation and MTF alignment but board exit + divided analysts and short float 15.9% add friction.
9	ONON	BUY PULLBACK	6.4	Strong forecasts and near_term 1.0 but just dropped 17.8% on mixed Q2 with lower-end guidance — let the dust settle.
10	TMUS	WAIT	6.2	Quality name but 1wk forecasts all negative and 'earnings loser with downside ahead' headline; forecasts modest.
11	VST	WAIT	6.0	Near-term bullish but 1wk forecasts crater (-40 to -60%) — story stock with data center risk digesting.
12	WING	BUY PULLBACK	5.9	Huge 1d fc (+83/+96%) and -42% weekly dd, but 'growth losing steam' headline and short float 15.7% cautionary.
13	PSN	BUY PULLBACK	5.8	$40M Army contract catalyst and near_term 1.0, but PEG 2.07 and salesYoY -5.84% show growth stalled.
14	PFSI	WAIT	5.6	EPS growth 102% and cheap (fwdPe 7.01) but recom 2.0 (weakest) and PT recently cut 13.6%.
15	ORCL	WAIT	5.5	Near top of range on 1d (84.55%), 1wk forecasts all negative, layoff rumors — chase risk.
16	CHWY	WAIT	5.4	1d fc solid (+32%) but 1h/4h forecasts negative, 'CHWY is risky' headline, insider selling.
17	PRIM	BUY PULLBACK	5.3	Huge 4h fc (+72%) but 1wk fc catastrophic (-38/-41%), UBS PT cut — mixed signal.
18	MIR	WAIT	5.2	Solid short-term fc but PE 173, PEG 1.19, both Citi and B.Riley cut PTs; 1wk fc negative.
19	ETOR	WAIT	5.0	bullish_prob null and only 2 TFs available, RSI 23.5 deeply oversold but 'fairly valued after 42% slump' caps upside.
20	MNDY	AVOID	4.7	Wolfe downgrade, 'growth slows' narrative, 1h/4h forecasts negative — thesis breaking.
21	TMDX	AVOID	4.6	RSI 69.5 and pos_in_range 98.77% on 4h = chased, targetUpside only 8.9%, 'margins down, trials delayed' headline.
22	APP	AVOID	4.4	BofA downgrade + 'growth target harder to defend' + 1wk fc catastrophic (-13/-36/-44%) — broken.
23	NRG	AVOID	4.3	1wk forecasts -29/-29%, 'shares crashing' headline — deteriorating trend.
24	FUTU	AVOID	4.0	DOJ probe + Hong Kong SFC asset freeze (even if not under investigation) — regulatory landmine.
25	KVYO	AVOID	4.0	PE 866, 'reduced gross margin outlook' and 1h/1d fc_short negative — valuation and momentum broken.
26	SPOT	AVOID	3.9	1wk forecasts -6/-19/-21%, near_term_bullish only 0.2, weakest MTF alignment among covered names.
27	BROS	AVOID	3.8	fwdPe 39.23, PEG 1.39, 1wk fc mid -9.78%, 30%+ drawdown but forecasts unimpressive.
28	KNF	AVOID	3.6	PEG 1.6, modest forecasts, JPM PT cut, revenue beat but profit miss — no edge.
29	SRAD	AVOID	3.2	UBS downgrade + cut 2026 outlook + down 16.7% on Q2 — thesis materially broken.
30	CELH	AVOID	3.0	PE 121, exec shake-up, 'still trades at premium after setbacks', 4h fc_short -8.91% — avoid.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord